GENOSCIENCE PHARMA
🏢 View company profile →4Patents
4Active
4Granted
44Portfolio score
Filing activity: Mar 13, 2014 → Aug 1, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10179770B2 | Quinolines derivatives as novel anticancer agents | Chemistry; Metallurgy | 0 | Active |
| US10722505B2 | Substituted 2,4 diamino-quinoline as new anticancer agents | Chemistry; Metallurgy | 0 | Active |
| US10577362B2 | Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases | Human Necessities | 0 | Active |
| US11261189B2 | Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins B (CTSB), L (CTSL) and D (CTSD) related diseases | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.